SOX6 and melanoma: Notably, the C1 and C2 cell subpopulations - characterized by high SOX6 expression - were functionally validated through SOX6 overexpression (SOX6_OE) and knockout (SOX6_KO) models to promote glycolytic dysregulation in melanoma cells [27].